News

September 9, 2020

Newly developed bioink enhances the ability of implanted cells to grow and regenerate new tissue 

(LOS ANGELES) – Engineering new tissues can be used to alleviate shortages of organs in transplantation, as well as to develop physiological models for drug discovery applications. One of the emerging approaches to building tissues is through 3D Printing, where cells and materials can be combined to make inks that can generate tissue structures. One of the limitations for making new tissues is that they require oxygen to survive. This oxygen is delivered through blood vessels, which take a few days to develop in a transplanted tissue.  

Read more ...

September 4, 2020

Researchers describe ways to achieve optimal patient advocacy for kidney recipients and donors during the COVID-19 pandemic and beyond 

(LOS ANGELES) – In a newly published paper, the authors first paint the vision of what optimal patient advocacy can do to overcome the challenges described by kidney transplant patients and donors, and then describe how to make that vision a reality, especially during the COVID-19 pandemic. Dr. Amy Waterman, Deputy Director at the Terasaki Institute for Biomedical Innovation and leader of the Transplant Research and Education Center (TREC), assembled a panel of patients to learn their priorities for their care during this unprecedented time. 

Read more ...

August 18, 2020

(LOS ANGELES) – The National Academy of Inventors (NAI) has elected Ali Khademhosseini, Ph.D., of the Terasaki Institute for Biomedical Innovation, to the rank of NAI Senior Member.  The NAI Senior Member Advisory Committee has chosen to honor him for his achievements and contributions to the innovation ecosystem at the NAI Member Institution, and he will be recognized formally at their tenth anniversary annual meeting on June 7-9, 2021. 

Read more ...

August 18, 2020

(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to welcome Maurizio Vecchione as its Chief Innovation Officer.  Maurizio has spent the last 30 years at the forefront of global and public health, focusing on innovation to improve the lives of the world’s most vulnerable people. From 2014 until 2020, he was the Executive Vice President for Global Good and Research at Intellectual Ventures (IV), where he oversaw collaboration with Bill Gates to invent and deploy technology to address some of humanity’s most daunting challenges.

Read more ...

August 5, 2020

A recent study published in the Journal of Biomedical Semantics performed an analysis and ranking of the most prominent, influential and prolific authors in the rapidly expanding field of 3D bioprinting.  The findings revealed that Ali Khademhosseini, Ph.D., of the Terasaki Institute for Biomedical Innovation, ranked as the second-most prolific author in terms of productivity, citation impact, and collaborative networking. 

Read more ...

July 28, 2020

Dr. Ali Khademhosseini of the Terasaki Institute for Biomedical Innovation (TIBI) has been awarded a fellowship from the International Association of Advanced Materials (IAAM), for him and his team’s groundbreaking work in precision medicine and the facilitation of its real-world applications in the public health field. He has most notably led the effort in tissue engineering, developing smart devices and materials for diagnostics and therapeutic drug delivery, and perfecting 3D-printed architectures of personalized surgical implants for patients in need. He is distinguished among the brightest and most impactful scientists for his commitment to assure and distribute his knowledge and methods of personalized health to as many people in need as possible.

Read more ...

July 20, 2020

From the burgeoning field of biomedical engineering and the ever-present need to provide solutions for medical problems, a new resource has been created that joins engineering technologies with biological research and medicine.  A comprehensive new book entitled “Interfacing Bioelectronics and Biomedical Sensing,” and co-edited by Ali Khademhosseini of the Terasaki Institute for Biomedical Engineering, Hung Cao of UC Irvine, Todd Coleman of UC San Diego and Tzung Hsiai from UCLA, has been recently published by Springer Nature.   

Read more ...

July 13, 2020

Component of tissue is shown to limit the amount of scarring after heart attack. 

(LOS ANGELES) –  When a person has a heart attack, the person’s coronary artery is blocked, cutting off the flow of blood and oxygen to that portion of the person’s heart.  The surrounding heart muscle may be damaged to an extent depending on the size of the blocked area and the time between the attack and treatment. Upon recovery, the heart muscle starts to heal, and like a skin wound, it may form a scar.  The size and location of the scar can vary greatly, and there is a possibility to develop additional complications or even death. 

Read more ...